FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Asks Advisors View on Diabetes Drug Heart Risk

[ Price : $8.95]

FDA medical reviewers raise a concern about cardiovascular safety for Novo Nordisks insulin degludec products.

Ireland Moves from Legislation Office to Advise Hamburg

[ Price : $8.95]

FDA commissioner Margaret Hamburg moves assistant commissioner for legislation Jeanne Ireland from the legislative shop to assume ...

Medivation Gets 5-page FDA-483 on Sponsor Monitoring

[ Price : $8.95]

FDA cites Medivation for sponsor monitor deficiencies in a just-released five-page FDA-483.

Roxane Labs Urges FDA to Reject Xyrem Petition

[ Price : $8.95]

Roxane Laboratories urges FDA to deny a Jazz Pharmaceuticals citizen petition seeking to block generic copies of Xyrem (sodium oxy...

Ventrus Plans NDA for Anal Fissure Cream

[ Price : $8.95]

Ventrus Biosciences says it will file an NDA for diltiazem hydrochloride cream for treating anal fissures in the fourth quarter ne...

FDA Panel Backs Raxibacumab for Anthrax

[ Price : $8.95]

FDAs Anti-Infective Drugs Advisory Committee votes in favor of GlaxoSmithKlines raxibacumab for treating inhalational anthrax.

FDA Warns Device Marketer for Unapproved Claims

[ Price : $8.95]

FDA warns a Tennessee Internet marketer that claims on its site and links to others make a light therapy product an unapproved and...

FDA-483 Cites Lab Vision Complaint Procedures

[ Price : $8.95]

An FDA inspection earlier this year of Lab Vision Corp. cites the firm over its complaint handling procedures.

USP Revises Heparin Labeling Requirements

[ Price : $8.95]

The U.S. Pharmacopeial Convention finalizes a standards revision to heparin sodium injections and heparin lock flush solutions tha...

Unusual Generic Design Defect Claim Survives Preemption

[ Price : $8.95]

A legal analysis by Dechert LLP attorney Michelle Hart Yeary reviews how an unusual generic design defect claim survived a preempt...